This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
875 posters, 25 topics, 3,440 authors, 1,061 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
March 25-28, 2026 | Tampa, FL, USA

P699
William M Rice, Austin James, Nicholas Rouck, Maren Sword, Rishab Agarwal, Fang Fang, Jessica Burgess
Miscellaneous / Other
Introduction
Peritoneal dialysis (PD) is an increasingly popular modality of renal replacement therapy for end-stage renal disease, but catheter obstruction or migration can compromise patency. Prophylactic techniques to increase catheter patency such as catheter-pexy (CP) and omentopexy have been described as possible adjuncts but have not yet been studied in a large cohort. We hypothesized that prophylactic CP would be associated with improved 1-year PD catheter patency.
Methods
This retrospective cohort study included patients aged 18-89 who underwent PD catheter insertion at a single tertiary care facility between 2016-2023. Data were obtained via electronic medical records. Patients were excluded if they underwent transplant, died, or voluntarily switched to hemodialysis unrelated to PD catheter malfunction within 1 year of the index insertion. The primary exposure was CP during PD catheter insertion. The primary outcome was 1-year patency, defined as the absence of revision or removal surgeries within 1 year of the index insertion. Covariates included demographics, obesity classification, comorbidities, and concomitant omentopexy during PD catheter insertion. Mann-Whitney-U and chi-squared compared baseline differences between CP and no-CP groups. Multivariable logistic regression analyzed the association of CP with 1-year catheter patency. P-values <0.05 were statistically significant.
Results
Of 524 patients identified, 449 were included in the final analysis. Of those, 345 (76.8%) had prophylactic CP and 104 (23.2%) did not. All baseline characteristics were similar between groups, except for more frequent concomitant omentopexy in the CP group (35.7%) compared to the no-CP group (20.2%) (p=0.03). There was no difference in 1-year patency rates between the CP group (70.1%) and the no-CP group (70.2%) (p=0.99). When stratified by type of reoperation within 1 year, there was a trend towards more catheter removals in the CP group (17.1% vs. 9.6%, p=0.06) and more revisions in the no-CP group (15.4% vs. 10.1%, p=0.14). After multivariable regression, CP was not associated with 1-year patency (OR 0.94, 95% CI [0.56, 1.58]). Importantly, neither obesity class I (OR 0.51, 95% CI [0.26, 1.02]), class II (OR 1.20, 95% CI [0.58, 2.48]), nor class III (OR 0.84, 95% CI [0.43, 1.63]) were associated with reoperation within 1-year.
Conclusion
This large cohort study found no evidence that prophylactic CP improves 1-year PD catheter patency. Additionally, although obesity is considered a relative contraindication to PD, 1-year outcomes were not inferior for this cohort. Further research focusing on prospective randomized trials may clarify subgroups that could benefit from prophylactic strategies.